Dataset Viewer
Auto-converted to Parquet Duplicate
patient_id
string
age_range
string
age_midpoint
float64
gender
string
ethnicity
string
region
string
icd10_code
string
condition
string
severity
string
onset_year
int64
medication
string
num_visits
float64
adherence_pct
float64
systolic_bp
float64
diastolic_bp
float64
heart_rate
float64
cholesterol_mg_dl
float64
bmi
float64
outcome
string
adverse_outcome
int64
gender_enc
int64
ethnicity_enc
int64
region_enc
int64
severity_enc
int64
icd10_code_enc
int64
P-A476F742
30-44
52
Female
Hispanic
Central
M54
Back Pain
Moderate
2,010
Metformin
8
100
121
74
75
188
27.7
Recovered
0
0
2
0
1
8
P-20B3C58F
30-44
37
Male
White
West
J45
Asthma
Moderate
2,021
Atorvastatin
6
73
123
76
76
181
30.9
Stable
0
1
4
4
1
6
P-BF5527D7
0-17
8
Male
Black
Central
K21
GERD
Severe
2,023
Lisinopril
4
46
92
53
78
194
26.4
Recovered
0
1
1
0
2
7
P-18E4D7DD
75-99
87
Female
White
North
I25
Coronary Artery Disease
Mild
2,014
Lisinopril
8
78
189
114
70
247
28.9
Deceased
1
0
4
2
0
5
P-9D97CFD0
60-74
67
Male
White
Central
E11
Type 2 Diabetes
Severe
2,018
Metformin
10
96
151
98
75
255
33.4
Deteriorated
1
1
4
0
2
1
P-6852836F
75-99
87
Female
White
South
E11
Type 2 Diabetes
Mild
2,017
Metformin
8
77
145
88
78
292
38.9
Deteriorated
1
0
4
3
0
1
P-510FCA3C
45-59
52
Male
Hispanic
Central
J45
Asthma
Mild
2,016
Sertraline
2
56
138
78
92
214
30.7
Deteriorated
1
1
2
0
0
6
P-B6181CFC
18-29
23
Non-binary
Hispanic
West
M54
Back Pain
Moderate
2,011
Albuterol
6
100
126
80
77
170
27.2
Recovered
0
2
2
4
1
8
P-4B3159A3
45-59
52
Female
White
West
I25
Coronary Artery Disease
Moderate
2,020
Omeprazole
5
57
178
120
79
270
29.6
Deceased
1
0
4
4
1
5
P-3C2A9E41
75-99
87
Male
Black
East
N18
Chronic Kidney Disease
Mild
2,020
Lisinopril
6
47
174
116
68
211
27.3
Recovered
0
1
1
1
0
9
P-45864796
75-99
87
Female
Hispanic
West
I25
Coronary Artery Disease
Mild
2,009
Lisinopril
4
76
183
113
78
223
27.3
Deteriorated
1
0
2
4
0
5
P-99AF5191
30-44
52
Female
White
Central
N18
Chronic Kidney Disease
Mild
2,006
Lisinopril
6
94
148
85
67
201
22.6
Stable
0
0
4
0
0
9
P-3182245F
75-99
52
Male
White
North
C34
Lung Cancer
Severe
2,014
Omeprazole
5
68
149
84
76
235
31.3
Deteriorated
1
1
4
2
2
0
P-4A4B924A
45-59
52
Male
Hispanic
North
I25
Coronary Artery Disease
Mild
2,007
Albuterol
5
70
159
88
73
251
20.1
Stable
0
1
2
2
0
5
P-0575DC9F
45-59
52
Female
Black
South
F32
Depression
Mild
2,025
Lisinopril
5
85
131
80
77
218
22.3
Stable
0
0
1
3
0
2
P-06AE374C
45-59
52
Female
Hispanic
North
M54
Back Pain
Mild
2,017
Albuterol
12
54
144
89
79
223
32
Deteriorated
1
0
2
2
0
8
P-C156E211
45-59
52
Male
Hispanic
South
I25
Coronary Artery Disease
Mild
2,015
Amlodipine
4
73
145
105
68
210
22.2
Stable
0
1
2
3
0
5
P-9E870580
30-44
37
Female
White
West
C34
Lung Cancer
Severe
2,023
Omeprazole
7
74
134
74
74
171
22.3
Deteriorated
1
0
4
4
2
0
P-1FDE9954
0-17
8
Male
Hispanic
Central
E11
Type 2 Diabetes
Mild
2,016
Amlodipine
6
59
120
75
86
219
33.6
Deteriorated
1
1
2
0
0
1
P-10C2A896
18-29
23
Male
White
East
M54
Back Pain
Mild
2,025
Gabapentin
4
89
123
81
75
168
24.3
Recovered
0
1
4
1
0
8
P-AA8D920A
18-29
23
Male
White
West
I10
Hypertension
Severe
2,019
Gabapentin
2
72
141
90
71
192
23.9
Recovered
0
1
4
4
2
4
P-9C6D1E2E
75-99
87
Male
White
West
G35
Multiple Sclerosis
Mild
2,016
Sertraline
8
53
145
104
73
257
29.8
Deteriorated
1
1
4
4
0
3
P-50403BFA
45-59
52
Female
Hispanic
North
I25
Coronary Artery Disease
Moderate
2,025
Metformin
4
74
165
95
76
228
23.2
Recovered
0
0
2
2
1
5
P-76BE7D0A
45-59
52
Non-binary
White
West
N18
Chronic Kidney Disease
Moderate
2,023
Omeprazole
4
71
162
100
69
246
26.7
Deceased
1
2
4
4
1
9
P-4C218C2A
45-59
52
Female
White
West
E11
Type 2 Diabetes
Moderate
2,019
Albuterol
5
64
132
77
70
232
32.4
Stable
0
0
4
4
1
1
P-96B4DD89
75-99
87
Female
White
Central
J45
Asthma
Moderate
2,020
Omeprazole
5
78
150
88
75
211
25.3
Recovered
0
0
4
0
1
6
P-FA917AD8
60-74
67
Female
White
Central
E11
Type 2 Diabetes
Moderate
2,025
Gabapentin
4
85
147
93
64
224
31.8
Stable
0
0
4
0
1
1
P-DC9EAFCE
75-99
87
Male
White
East
E11
Type 2 Diabetes
Mild
2,023
Amlodipine
3
63
182
119
76
268
33.4
Deteriorated
1
1
4
1
0
1
P-CB171FDA
75-99
87
Female
White
North
I25
Coronary Artery Disease
Mild
2,007
Omeprazole
5
70
167
100
74
202
27.8
Stable
0
0
4
2
0
5
P-0491082F
18-29
23
Male
Asian
West
N18
Chronic Kidney Disease
Mild
2,024
Amlodipine
6
75
146
98
72
186
28.8
Stable
0
1
0
4
0
9
P-9ABCFCF0
30-44
37
Non-binary
White
East
I10
Hypertension
Mild
2,016
Atorvastatin
6
93
159
95
78
218
29.2
Deteriorated
1
2
4
1
0
4
P-818E3CB4
45-59
52
Female
White
South
G35
Multiple Sclerosis
Mild
2,022
Omeprazole
9
74
142
79
69
200
30.6
Recovered
0
0
4
3
0
3
P-73BC2C33
45-59
52
Female
Hispanic
East
N18
Chronic Kidney Disease
Mild
2,016
Albuterol
11
98
161
101
75
221
31.3
Deteriorated
1
0
2
1
0
9
P-B752A433
60-74
67
Male
White
Central
N18
Chronic Kidney Disease
Severe
2,009
Gabapentin
5
81
182
107
82
245
30.3
Deceased
1
1
4
0
2
9
P-7D0BD159
60-74
67
Male
White
North
E11
Type 2 Diabetes
Mild
2,015
Atorvastatin
14
73
146
94
86
239
33.7
Deteriorated
1
1
4
2
0
1
P-1CB14D2E
0-17
8
Female
Hispanic
North
G35
Multiple Sclerosis
Moderate
2,008
Sertraline
3
74
125
72
74
212
22.3
Recovered
0
0
2
2
1
3
P-FCD986DB
60-74
67
Female
White
South
M54
Back Pain
Moderate
2,023
Omeprazole
8
84
155
98
78
221
23.9
Stable
0
0
4
3
1
8
P-D348F540
60-74
67
Female
White
East
N18
Chronic Kidney Disease
Mild
2,022
Albuterol
5
77
163
98
74
197
24.9
Recovered
0
0
4
1
0
9
P-55E3ABAE
18-29
23
Male
White
North
N18
Chronic Kidney Disease
Moderate
2,016
Amlodipine
14
52
144
86
75
184
27.8
Recovered
0
1
4
2
1
9
P-22652694
60-74
67
Female
Asian
South
J45
Asthma
Mild
2,022
Lisinopril
7
75
145
89
82
234
30.8
Stable
0
0
0
3
0
6
P-58A2DBCA
75-99
87
Male
White
Central
I25
Coronary Artery Disease
Moderate
2,022
Sertraline
5
68
180
112
75
258
29.6
Stable
0
1
4
0
1
5
P-A1AC460A
75-99
87
Female
Black
Central
G35
Multiple Sclerosis
Mild
2,011
Omeprazole
5
96
152
94
64
210
26.9
Recovered
0
0
1
0
0
3
P-1EAA4024
60-74
67
Female
Asian
Central
N18
Chronic Kidney Disease
Severe
2,024
Metformin
5
78
171
98
67
234
33
Deteriorated
1
0
0
0
2
9
P-0CFE5D36
45-59
52
Male
White
South
I10
Hypertension
Mild
2,014
Gabapentin
2
85
156
95
62
205
27.9
Recovered
0
1
4
3
0
4
P-74EC783B
45-59
52
Male
White
South
C34
Lung Cancer
Mild
2,009
Albuterol
5
59
150
97
83
211
29.1
Deteriorated
1
1
4
3
0
0
P-9FD2AEC5
60-74
52
Male
Hispanic
South
I10
Hypertension
Moderate
2,016
Metformin
4
85
174
117
69
211
27.7
Deteriorated
1
1
2
3
1
4
P-4AA2D31B
0-17
8
Female
Hispanic
North
C34
Lung Cancer
Moderate
2,009
Atorvastatin
5
82
113
73
88
214
28.2
Deteriorated
1
0
2
2
1
0
P-1948500A
18-29
23
Female
White
East
N18
Chronic Kidney Disease
Mild
2,013
Metformin
7
95
158
87
71
203
32.3
Deceased
1
0
4
1
0
9
P-53EADE03
60-74
67
Male
White
South
C34
Lung Cancer
Severe
2,012
Amlodipine
6
57
170
104
75
231
31.5
Deceased
1
1
4
3
2
0
P-D7BAB1A2
75-99
52
Male
White
East
C34
Lung Cancer
Mild
2,018
Atorvastatin
4
54
150
95
87
237
30.9
Deteriorated
1
1
4
1
0
0
P-593A8083
45-59
52
Male
White
West
E11
Type 2 Diabetes
Moderate
2,007
Lisinopril
6
50
123
70
82
229
39.8
Deteriorated
1
1
4
4
1
1
P-419E2A9D
45-59
52
Female
White
East
I10
Hypertension
Mild
2,023
Albuterol
1
86
161
103
62
208
23.1
Stable
0
0
4
1
0
4
P-AFDEAF57
60-74
67
Male
White
South
C34
Lung Cancer
Severe
2,016
Sertraline
4
72
158
103
71
192
26.3
Recovered
0
1
4
3
2
0
P-F5D7245A
60-74
67
Female
Other
East
I25
Coronary Artery Disease
Severe
2,019
Gabapentin
5
75
169
95
59
214
27.8
Stable
0
0
3
1
2
5
P-6BE34908
45-59
52
Female
White
North
I10
Hypertension
Moderate
2,025
Albuterol
4
51
151
95
81
169
28
Stable
0
0
4
2
1
4
P-468FF01C
60-74
67
Male
Asian
West
C34
Lung Cancer
Moderate
2,012
Atorvastatin
4
93
157
88
80
238
27.8
Deteriorated
1
1
0
4
1
0
P-03FA05E5
45-59
52
Male
White
West
E11
Type 2 Diabetes
Mild
2,021
Amlodipine
5
64
133
76
75
224
36.9
Recovered
0
1
4
4
0
1
P-DDE07C62
60-74
67
Female
Asian
South
F32
Depression
Mild
2,022
Omeprazole
3
66
145
82
70
195
32
Recovered
0
0
0
3
0
2
P-9231C3EB
30-44
37
Male
Black
Central
C34
Lung Cancer
Mild
2,021
Omeprazole
3
86
134
77
75
208
27.3
Recovered
0
1
1
0
0
0
P-64EEAD9F
30-44
37
Male
Hispanic
West
C34
Lung Cancer
Moderate
2,006
Lisinopril
9
69
136
75
72
218
29.9
Deteriorated
1
1
2
4
1
0
P-819E165C
30-44
37
Female
Black
Central
N18
Chronic Kidney Disease
Moderate
2,014
Amlodipine
6
74
140
87
82
192
24.9
Stable
0
0
1
0
1
9
P-6FDE9449
30-44
52
Female
White
North
K21
GERD
Severe
2,023
Gabapentin
5
91
141
88
70
167
22.6
Recovered
0
0
4
2
2
7
P-631056EB
30-44
37
Male
White
West
J45
Asthma
Moderate
2,019
Lisinopril
4
86
135
74
66
211
28
Recovered
0
1
4
4
1
6
P-68DB5112
45-59
52
Female
Asian
South
I10
Hypertension
Mild
2,016
Omeprazole
3
66
153
91
68
211
29.1
Stable
0
0
0
3
0
4
P-7628DA00
60-74
67
Male
White
East
I10
Hypertension
Moderate
2,025
Amlodipine
8
71
171
102
69
194
26.3
Stable
0
1
4
1
1
4
P-ECBEF239
60-74
67
Male
Hispanic
North
N18
Chronic Kidney Disease
Mild
2,009
Atorvastatin
7
100
165
94
75
187
25.7
Recovered
0
1
2
2
0
9
P-9D627D8D
75-99
87
Male
White
North
N18
Chronic Kidney Disease
Mild
2,007
Sertraline
6
82
184
107
85
242
29.7
Deteriorated
1
1
4
2
0
9
P-A952DA5D
45-59
52
Female
White
East
K21
GERD
Mild
2,011
Atorvastatin
6
86
139
88
59
170
27.8
Recovered
0
0
4
1
0
7
P-99B7575D
45-59
52
Female
White
West
I25
Coronary Artery Disease
Mild
2,022
Atorvastatin
9
64
152
85
95
237
30.8
Deceased
1
0
4
4
0
5
P-D6C22B9F
45-59
52
Male
White
Central
N18
Chronic Kidney Disease
Severe
2,008
Gabapentin
8
70
155
93
75
202
20.7
Stable
0
1
4
0
2
9
P-3035C5EF
45-59
52
Male
White
East
I25
Coronary Artery Disease
Severe
2,018
Sertraline
5
85
180
116
82
233
28.1
Deteriorated
1
1
4
1
2
5
P-83ACB4BF
75-99
87
Male
White
East
N18
Chronic Kidney Disease
Mild
2,022
Albuterol
8
76
194
120
75
227
31.1
Deteriorated
1
1
4
1
0
9
P-20BEA719
18-29
23
Female
Hispanic
West
G35
Multiple Sclerosis
Moderate
2,007
Gabapentin
7
61
143
82
85
195
27.1
Deceased
1
0
2
4
1
3
P-A9F014D0
18-29
52
Female
White
North
F32
Depression
Moderate
2,018
Lisinopril
5
92
143
85
76
181
29.8
Stable
0
0
4
2
1
2
P-0972C530
45-59
52
Female
Other
West
E11
Type 2 Diabetes
Severe
2,010
Lisinopril
6
59
136
79
67
198
30
Stable
0
0
3
4
2
1
P-007C027B
30-44
37
Female
White
North
I25
Coronary Artery Disease
Moderate
2,018
Sertraline
2
87
157
88
79
254
29.5
Stable
0
0
4
2
1
5
P-4EDA578F
60-74
67
Female
White
East
I25
Coronary Artery Disease
Moderate
2,010
Sertraline
6
84
148
96
71
219
21.3
Stable
0
0
4
1
1
5
P-EDA88D7D
60-74
67
Female
White
South
E11
Type 2 Diabetes
Mild
2,012
Amlodipine
5
56
139
79
72
243
34.5
Stable
0
0
4
3
0
1
P-23D2547A
45-59
52
Male
Hispanic
West
C34
Lung Cancer
Severe
2,009
Gabapentin
3
64
145
79
88
210
35.3
Deteriorated
1
1
2
4
2
0
P-B90D1E65
45-59
52
Female
White
West
N18
Chronic Kidney Disease
Mild
2,011
Albuterol
7
74
164
102
79
202
23.1
Deteriorated
1
0
4
4
0
9
P-223DB4FA
60-74
67
Female
White
East
J45
Asthma
Moderate
2,006
Amlodipine
6
72
142
92
87
199
28.7
Recovered
0
0
4
1
1
6
P-C4FC3464
75-99
87
Female
Hispanic
North
E11
Type 2 Diabetes
Mild
2,010
Amlodipine
10
100
143
80
64
255
27.6
Recovered
0
0
2
2
0
1
P-1B13697A
60-74
67
Female
White
West
F32
Depression
Mild
2,024
Omeprazole
5
58
148
97
70
209
27.8
Stable
0
0
4
4
0
2
P-7293FBFA
60-74
67
Male
White
South
I25
Coronary Artery Disease
Mild
2,019
Metformin
6
42
176
88
74
264
27.5
Deteriorated
1
1
4
3
0
5
P-005F55A7
60-74
67
Female
Asian
North
E11
Type 2 Diabetes
Severe
2,011
Amlodipine
10
68
159
88
75
248
30.6
Deteriorated
1
0
0
2
2
1
P-1279FAB0
60-74
67
Male
White
East
I10
Hypertension
Mild
2,008
Atorvastatin
5
57
172
95
76
210
24.4
Stable
0
1
4
1
0
4
P-3A474808
75-99
87
Female
Asian
North
G35
Multiple Sclerosis
Severe
2,024
Lisinopril
7
69
177
117
78
240
25.1
Deteriorated
1
0
0
2
2
3
P-BCF393C8
75-99
87
Female
Other
North
K21
GERD
Mild
2,025
Omeprazole
5
71
142
81
76
205
27.7
Stable
0
0
3
2
0
7
P-8EF418B8
30-44
37
Male
White
South
C34
Lung Cancer
Mild
2,011
Metformin
8
93
129
82
82
205
28.8
Deteriorated
1
1
4
3
0
0
P-A00F3CA5
60-74
67
Non-binary
White
North
G35
Multiple Sclerosis
Severe
2,016
Sertraline
8
68
152
86
73
201
27.8
Recovered
0
2
4
2
2
3
P-2BFD1A84
18-29
23
Female
White
South
G35
Multiple Sclerosis
Mild
2,008
Lisinopril
5
63
123
79
78
183
23.6
Recovered
0
0
4
3
0
3
P-E597E9C6
60-74
67
Male
Black
East
I10
Hypertension
Moderate
2,024
Gabapentin
12
82
180
110
85
212
26.7
Deteriorated
1
1
1
1
1
4
P-AE5735DC
60-74
67
Female
Black
Central
I25
Coronary Artery Disease
Moderate
2,022
Atorvastatin
8
67
160
88
84
270
29.3
Deteriorated
1
0
1
0
1
5
P-CE0560B3
30-44
37
Female
Hispanic
West
M54
Back Pain
Severe
2,010
Atorvastatin
6
67
145
80
75
201
17.5
Stable
0
0
2
4
2
8
P-B7559794
30-44
37
Male
White
South
I25
Coronary Artery Disease
Mild
2,024
Sertraline
3
50
139
94
64
228
23
Recovered
0
1
4
3
0
5
P-6165EBE2
45-59
52
Female
White
North
E11
Type 2 Diabetes
Mild
2,019
Metformin
2
92
137
80
79
220
32.6
Recovered
0
0
4
2
0
1
P-5CF5B436
45-59
52
Male
White
South
M54
Back Pain
Mild
2,021
Gabapentin
7
75
137
86
70
182
27.7
Recovered
0
1
4
3
0
8
P-8EDD709B
45-59
52
Male
Other
West
I10
Hypertension
Moderate
2,024
Gabapentin
5
64
159
93
79
238
26.1
Recovered
0
1
3
4
1
4
P-B0AB2D96
45-59
52
Male
Asian
Central
N18
Chronic Kidney Disease
Mild
2,020
Gabapentin
5
87
160
104
71
211
23.6
Stable
0
1
0
0
0
9
P-A4DF5232
45-59
52
Male
White
East
C34
Lung Cancer
Moderate
2,024
Lisinopril
3
74
129
86
84
225
24.1
Recovered
0
1
4
1
1
0
End of preview. Expand in Data Studio

YAML Metadata Warning:The task_ids "binary-classification" is not in the official list: acceptability-classification, entity-linking-classification, fact-checking, intent-classification, language-identification, multi-class-classification, multi-label-classification, multi-input-text-classification, natural-language-inference, semantic-similarity-classification, sentiment-classification, topic-classification, semantic-similarity-scoring, sentiment-scoring, sentiment-analysis, hate-speech-detection, text-scoring, named-entity-recognition, part-of-speech, parsing, lemmatization, word-sense-disambiguation, coreference-resolution, extractive-qa, open-domain-qa, closed-domain-qa, news-articles-summarization, news-articles-headline-generation, dialogue-modeling, dialogue-generation, conversational, language-modeling, text-simplification, explanation-generation, abstractive-qa, open-domain-abstractive-qa, closed-domain-qa, open-book-qa, closed-book-qa, text2text-generation, slot-filling, masked-language-modeling, keyword-spotting, speaker-identification, audio-intent-classification, audio-emotion-recognition, audio-language-identification, multi-label-image-classification, multi-class-image-classification, face-detection, vehicle-detection, instance-segmentation, semantic-segmentation, panoptic-segmentation, image-captioning, image-inpainting, image-colorization, super-resolution, grasping, task-planning, tabular-multi-class-classification, tabular-multi-label-classification, tabular-single-column-regression, rdf-to-text, multiple-choice-qa, multiple-choice-coreference-resolution, document-retrieval, utterance-retrieval, entity-linking-retrieval, fact-checking-retrieval, univariate-time-series-forecasting, multivariate-time-series-forecasting, visual-question-answering, document-question-answering, pose-estimation

πŸ₯ Synthetic Privacy-Preserving Medical EHR Dataset

Dataset Description

A fully synthetic collection of 10,000 Electronic Health Records (EHRs) for binary classification research. The task is predicting adverse patient outcomes β€” deterioration or death β€” from clinical, demographic, and vital sign features. No real patient data was used at any stage. Privacy-safe under GDPR, CCPA, and HIPAA.

Supported Tasks

  • tabular-classification: Predict adverse_outcome (0/1) from 13 clinical features
  • Benchmark models: Random Forest, Gradient Boosting, XGBoost
  • Class imbalance handling: SMOTE oversampling applied on training set only
  • Interpretability: SHAP feature importance included in generation pipeline

Dataset Structure

Split File Rows Strategy
train train.csv 7,000 70% stratified by target
validation val.csv 1,500 15% stratified by target
test test.csv 1,500 15% stratified by target
full full_dataset.csv 10,000 Complete unsplit dataset

Data Fields

Field Type Description
patient_id string UUID-based anonymous ID (e.g. P-3FA2C1B8)
age_range string Age bucket: 0-17 / 18-29 / 30-44 / 45-59 / 60-74 / 75-99
age_midpoint int32 Midpoint of age bucket β€” used as numeric ML feature
gender string Male / Female / Non-binary
ethnicity string White / Black / Hispanic / Asian / Other
region string North / South / East / West / Central
icd10_code string ICD-10 primary diagnosis code
condition string Hypertension, Diabetes, Cancer, etc.
severity string Mild / Moderate / Severe
onset_year int32 Year of diagnosis (2005–2025)
medication string Primary prescribed medication
num_visits int32 Number of provider visits
adherence_pct int32 Treatment adherence percentage 0–100
systolic_bp int32 Systolic blood pressure in mmHg
diastolic_bp int32 Diastolic blood pressure in mmHg
heart_rate int32 Heart rate in beats per minute
cholesterol_mg_dl int32 Total cholesterol in mg/dL
bmi float32 Body Mass Index
outcome string Recovered / Stable / Deteriorated / Deceased
adverse_outcome int32 TARGET 1 = Deteriorated or Deceased, 0 = otherwise

Privacy Methods

This dataset was synthetically generated in Python. Privacy techniques applied:

  1. Anonymization β€” UUID patient IDs, no real names or SSNs
  2. Generalization β€” age buckets, region labels instead of cities
  3. Differential Privacy β€” Laplace mechanism noise (epsilon=2.0) on all vital signs
  4. Data Perturbation β€” Gaussian noise on continuous features

No real patient records were used or referenced at any stage.

Benchmark Results

Model Val ROC-AUC Accuracy F1 Adverse CV 5-fold
Random Forest 0.9535 89% 0.82 0.9707 Β± 0.013
Gradient Boosting 0.9630 90% 0.84 0.9760 Β± 0.013
XGBoost (best) 0.9665 91% 0.85 0.9769 Β± 0.012
XGBoost (test) 0.9542 90% 0.85 β€”

Use Cases

  • Binary classification for healthcare outcome prediction
  • Benchmarking tabular ML models without privacy risk
  • Teaching SMOTE, scaling, hyperparameter tuning, SHAP
  • Fairness analysis across demographic groups
  • Differential privacy and privacy-preserving AI research

Citation

@dataset{mdsajjadullah_2025_synthetic_ehr,
  author    = {Md.Sajjad Ullah},
  title     = {Synthetic Privacy-Preserving Medical EHR Dataset},
  year      = {2025},
  publisher = {Zenodo},
  version   = {5.0},
  doi       = {10.5281/zenodo.18968480},
  url       = {https://doi.org/10.5281/zenodo.18968480}
}
Downloads last month
26